Ambrish Singh

· University of Tasmania
60h 指数
89,383总引用
185发文
87i10

简介

Dr. Ambrish Singh embarked on his academic journey by earning a Bachelor's in Pharmacy, followed by a Postgraduate Degree in Biotechnology from a prestigious biotech college in India. Over the course of nearly a decade, he honed his expertise in consulting, MedTech, and pharmaceutical industries, where he spearheaded numerous impactful projects in health economics and outcomes research (HEOR) and real-world evidence (RWE). Driven by a relentless pursuit of knowledge and innovation, he made the pivotal decision to further his education in epidemiology and health economics. Securing an international scholarship, Dr. Singh pursued a PhD at the Menzies Institute for Medical Research, University of Tasmania, Australia, culminating in a Major in Epidemiology and Health Economics. His doctoral research delved into unraveling the complexities of early knee osteoarthritis in young adults, leveraging data from the Childhood Determinants of Adult Health (CDAH) Study and contributing to the YOGA trial in knee osteoarthritis (ACTRN12621000066886). His expertise spans Real World Evidence, Patient Outcomes, Systematic Review, Meta-analysis, HEOR, Market Access, Global HTA & Reimbursement, Pharmacoeconomics, and Global Burden of Disease across various disease areas including Cardiovascular, Renal, Oncology, Diabetes, Depression, Rheumatology, Parkinson's disease, Osteoarthritis, Alzheimer's disease, among others. As an accomplished academic author, Dr. Singh has authored more than 100 peer-reviewed articles in HEOR, RWE, and epidemiology, gracing the pages of esteemed journals such as Lancet, JAMA, Annals of Internal Medicine, BMJ, Ageing Research Reviews, and Cochrane Database of Systematic Reviews. His collaborative efforts extend to projects with renowned international organizations including Cochrane, WHO, International Decision Support Initiative (iDSI), World Federation of Hemophilia, Joanna Briggs Institute, and Global Burden of Disease, contributing to evidence synthesis projects and publishing guidelines, systematic reviews, evidence summaries, and burden estimates. A dedicated member of scientific associations such as ISPE, ISPOR, and HTAi, Dr. Singh's contributions have been recognized with several scholarships and awards from esteemed international organizations. Noteworthy accolades include the following: 2019 Tasmania Graduate Research Scholarship for current PhD 2019 Travel grant to attend AKI CRRT 2019 annual conference, Kuala Lumpur, Malaysia 2019 First prize for oral presentation at AKI CRRT 2019 annual conference 2021 EULAR e-bursaries to attend the 2021 EULAR Virtual Congress 2021 ISOQOL e-bursaries to attend the 2021 ISOQOL Virtual Congress 2022 ICPE travel grant to attend the ICPE 2022 at Copenhagen, Denmark 2022 ICDM travel grant to attend the ICDM 2022 conference in Seoul, Korea 2022 MDS travel grant to attend the MDS 2022 annual conference in Barcelona, Spain 2022 Best overseas original work award for oral presentation at IRACON 2022 2023 ESCEO-IOF Young Investigator Award at WCO-IOF-ESCEO Barcelona 2023 2023 EULAR bursaries to attend the 2023 EULAR Congress in Milan, Italy 2023 KSN travel grant to attend KSN 2023 Annual meeting in Seoul, Korea 2023 KCR travel grant to attend LUPUS KCR 2023 Annual meeting in Seoul, Korea 2023 HTAi participation grant to attend HTAi 2023 Annual meeting, Adelaide, Australia

研究方向

Osteoarthritis Treatment and MechanismsRheumatoid Arthritis Research and TherapiesHealth Systems, Economic Evaluations, Quality of LifeGlobal Maternal and Child HealthDiabetes, Cardiovascular Risks, and Lipoproteins

University of Tasmania学位项目

该教授任职院校的热门项目 (PhD/Master 优先)

数据来源: OpenAlex + ORCID + Wikidata · 数据质量: verified

登录后开启学术探索

收藏教授 / 论文 / 学科排名, 订阅研究方向更新。登录后开启这些能力。

已有账号?